tiprankstipranks
Verrica Pharmaceuticals (VRCA)
NASDAQ:VRCA
US Market
VRCA
Verrica Pharmaceuticals
RESEARCH TOOLSreports
Want to see VRCA full AI Analyst Report?

Verrica Pharmaceuticals (VRCA) Income Statement

482 Followers

Verrica Pharmaceuticals Income Statement

Last quarter (Q4 2025), Verrica Pharmaceuticals's total revenue was $5.09M, an increase of 1380.23% from the same quarter last year. In Q4, Verrica Pharmaceuticals's net income was $-8.07M. See Verrica Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 35.58M$ 7.57M$ 5.12M$ 9.03M$ 12.00M
Gross Profit
$ 32.14M$ 4.83M$ 4.38M$ 8.31M$ 11.53M
Operating Expenses
$ 44.08M$ 70.75M$ 70.14M$ 29.60M$ 42.44M
Depreciation and Amortization
$ 781.00K$ 1.27M$ 836.00K$ 718.00K$ 472.00K
EBITDA
$ -11.16M$ -65.90M$ -62.20M$ -21.60M$ -30.31M
Operating Income
$ -11.94M$ -65.92M$ -65.76M$ -21.30M$ -30.91M
Other Income/Expenses
$ -5.95M$ -10.66M$ -1.24M$ -3.19M$ -4.17M
Pretax Income
$ -17.89M$ -76.58M$ -67.00M$ -24.49M$ -35.08M
Net Income
$ -17.89M$ -76.58M$ -67.00M$ -24.49M$ -35.08M
Per Share Metrics
Basic EPS
$ -1.68$ -14.78$ -14.78$ -7.17$ -12.97
Diluted EPS
$ -1.68$ -14.78$ -14.78$ -7.17$ -12.97
Weighted Average Shares Outstanding
 10.65M 5.18M 4.53M 3.42M 2.70M
Weighted Average Shares Outstanding (Diluted)
 10.65M 5.18M 4.53M 3.42M 2.70M
Currency in USD

Verrica Pharmaceuticals Earnings and Revenue History